Joel Greenblatt Tg Therapeutics, Inc. Transaction History
Gotham Asset Management, LLC
- $7.56 Billion
- Q2 2024
A detailed history of Joel Greenblatt (Gotham Asset Management, LLC) transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Gotham Asset Management, LLC holds 73,307 shares of TGTX stock, worth $1.57 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
73,307
Previous 71,576
2.42%
Holding current value
$1.57 Million
Previous $1.09 Million
19.85%
% of portfolio
0.02%
Previous 0.02%
Shares
14 transactions
Others Institutions Holding TGTX
# of Institutions
287Shares Held
91.8MCall Options Held
1.9MPut Options Held
1.45M-
Vanguard Group Inc Valley Forge, PA13.7MShares$294 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$244 Million0.0% of portfolio
-
State Street Corp Boston, MA6.7MShares$144 Million0.01% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT3.65MShares$78.2 Million6.57% of portfolio
-
Pictet Asset Management Holding Sa Carouge, V83.24MShares$69.6 Million0.07% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $3.12B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...